cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Stereotaxis Inc
7 own
15 watching
Current Price
$3.08
$0.28
(10%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
150.09M
52-Week High
52-Week High
3.14000
52-Week Low
52-Week Low
1.33000
Average Volume
Average Volume
0.6M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
-1.35714286
iconMarket Capitalization150.09M
icon52-Week High3.14000
icon52-Week Low1.33000
iconAverage Volume0.6M
iconDividend Yield--
iconP/E Ratio-1.35714286
What does the Stereotaxis Inc do?
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.
Read More
How much money does Stereotaxis Inc make?
News & Events about Stereotaxis Inc.
Globe Newswire
10 months ago
ST. LOUIS, April 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2023 first quarter on Tuesday, May 9, 2023 before the open of the ...
Globe Newswire
10 months ago
ST. LOUIS, April 13, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that over 1,000 cardiac arrhythmia patients have been treated using the Genesis Robotic Magnetic Navigation (RMN...
Globe Newswire
11 months ago
ST. LOUIS, March 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the grand opening of a new robotic electrophysiology program at Broward Health Medical Center in Fort Lauderdale, ...
Globe Newswire
11 months ago
ST. LOUIS, March 03, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth quarter and full year ended December 31, 2022. This year is poised to be an ...
Globe Newswire
12 months ago
ST. LOUIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Cowen 43rd Annual Health Care Conference. Mr. ...
Frequently Asked Questions
Frequently Asked Questions
What is Stereotaxis Inc share price today?
plus_minus_icon
Can Indians buy Stereotaxis Inc shares?
plus_minus_icon
How can I buy Stereotaxis Inc shares from India?
plus_minus_icon
Can Fractional shares of Stereotaxis Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Stereotaxis Inc stocks?
plus_minus_icon
What is today’s traded volume of Stereotaxis Inc?
plus_minus_icon
What is today’s market capitalisation of Stereotaxis Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Stereotaxis Inc?
plus_minus_icon
What percentage is Stereotaxis Inc down from its 52-Week High?
plus_minus_icon
What percentage is Stereotaxis Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.08
$0.28
(10%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00